What did the FDA find wrong with Cau Tre Export Goods Processing Joint Stock Company?

The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.

Are Cau Tre Export Goods Processing Joint Stock Company products safe to use?

Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.

What should I do if I've used Cau Tre Export Goods Processing Joint Stock Company products?

If you have used products from Cau Tre Export Goods Processing Joint Stock Company and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Cau Tre Export Goods Processing Joint Stock Company FDA Warn

Name: Cau Tre Export Goods Processing Joint Stock Company FDA Warn
Creator: Supplement Safety Data Team
Published: 2026-03-27T01:44:24.776088

Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on November 14, 2017

MODERATE SEVERITY 2017

Disclaimer: This report is an analysis of a public FDA warning letter. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately.

Executive Summary

The FDA issued a warning letter to Cau Tre Export Goods Processing Joint Stock Company on November 14, 2017 citing regulatory violations. The letter was issued by the FDA.

Regulatory Violations

Detailed Analysis

False Claims and Regulatory Violations

The FDA identified regulatory violations in Cau Tre Export Goods Processing Joint Stock Company's operations or product claims.

Potential Health Risks

Consumers should be aware of potential risks associated with products from Cau Tre Export Goods Processing Joint Stock Company.

Regulatory Context

The Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our Warning Letter # 442600 issued November 24,2014. Based on our evaluation, it appears you have addressed the violations contained in th442600e Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Robyn JonesDivision of EnforcementOffice of ComplianceCenter for Food Safety and Applied Nutrition

Key Entities Identified

Cau Tre Export Goods Processing Joint Stock Company FDA Warning Letter

Frequently Asked Questions

What did the FDA find wrong with Cau Tre Export Goods Processing Joint Stock Company?: The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
Are Cau Tre Export Goods Processing Joint Stock Company products safe to use?: Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
What should I do if I've used Cau Tre Export Goods Processing Joint Stock Company products?: If you have used products from Cau Tre Export Goods Processing Joint Stock Company and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Source Document

This report is based on an official FDA warning letter. The original document is a public record.

View Original FDA Warning Letter

Medical Disclaimer: This report is an analysis of public FDA warning letters. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately. You can report adverse events to the FDA MedWatch program.